Harrow posts record Q3 revenue and strong branded product growth

Harrow reported third‑quarter 2026 revenue of $99.3 million, up roughly 39% year‑over‑year, driven by branded sales of VEVYE, IHEEZO and TRIESENCE. Net income rose to $9.76 million, yielding diluted EPS of $0.25. The company closed its acquisition of TYRVAYA on October 1, 2026 and expects the product to add over $30 million in revenue in 2027.

The company reaffirmed its FY 2026 revenue guidance of $350 million‑$365 million but lowered its adjusted EBITDA outlook, indicating that while top‑line growth remains strong, profitability targets may be revised. Investors should note the $5 million litigation settlement gain and the upcoming contribution from TYRVAYA, which could boost 2027 revenue.

  • 1Q3 2026 revenue was $99.3 million, up 38.6% YoY.
  • 2Diluted EPS for the quarter was $0.25, up 333.3% YoY.
  • 3Branded product revenue was $83.5 million, representing about 84% of total revenue.
  • 4VEVYE generated $39.7 million in revenue, IHEEZO $25.3 million and TRIESENCE $10.7 million.
  • 5The company recorded a $5 million litigation settlement gain.
  • 6TYRVAYA acquisition closed on October 1, 2026; Harrow expects it to contribute more than $30 million in 2027.

Sources